COVID-19 patients can helped with the use of vitamin D, according to the latest reports. Here are more details about this below.
Vitamin D treatment for COVID-19
A recent study conducted in Japan has found that administering vitamin D supplements to hospitalized COVID-19 patients led to improved outcomes. The study aimed to investigate the potential of vitamin D in preventing severe illness and mortality among COVID-19 patients.
The researchers discovered that a large number of COVID-19 patients had a vitamin D deficiency, and supplementing their diet with vitamin D helped in alleviating their symptoms and facilitating recovery.
The treatment involved the use of a vitamin D analog known as alfacalcidol or 1-hydroxy-vitamin D, which is used to treat vitamin D deficiency-related disorders.
The study observed patients who were hospitalized twice for COVID-19 treatment. The first admission was between April 2021 and October 2021, during the Delta variant, and the second admission was between July 2022 and September 2022, during the Omicron variant.
Out of the total 312 COVID-19 patients in the study, 122 received Vitamin D treatment, while the remaining patients were placed in the control group.
The Vitamin D group included patients who were already taking alfacalcidol before admission. Both groups were provided with standard care, which included antiviral medications and/or systemic corticosteroid therapy.
The study found that patients in the control group had a more severe COVID-19 profile than those in the Vitamin D group. Additionally, 70% of all patients were found to be Vitamin D deficient.
The study also observed that the proportion of patients who were prescribed remdesivir was significantly higher in the Vitamin D group.
According to a study conducted at the Hamamatsu Medical Center in Japan, patients who were given vitamin D supplements had a significantly lower frequency of in-hospital mortality and the need for additional respiratory support when compared to the control group.
The research concluded that “1-hydroxy-vitamin may improve outcomes in hospitalized patients with COVID-19.”
The study also cited other research and reviews, which highlighted the potential benefit of vitamin D to COVID-19 patients.
One meta-analysis found that although vitamin D supplementation did not reduce mortality, it significantly reduced the rate of intubation and length of stay of COVID-19 patients.
Another meta-analysis concluded that vitamin D supplementation was associated with improved clinical outcomes regarding intensive care unit admission and/or mortality.
This was particularly true when patients were administered vitamin D after being diagnosed with COVID-19.
There were also research studies that recommended against using vitamin D among COVID-19 patients, the study pointed out. For instance, one review found that high doses of vitamin D were “ineffective” against COVID-19, it stated.
The study admitted to certain limitations in its analysis, including the fact that it was conducted at a single institution with a small sample size.
“Treatment with 1-hydroxy-vitamin D may suppress disease worsening in hospitalized patients with COVID-19.
Prospective randomized controlled trials are required to validate our findings,” it said.
Vitamin D Deficiency
A March 2021 study published in the Clinical Nutrition Journal revealed that most COVID-19 patients analyzed in the study suffered from vitamin D deficiency.
The study showed that low levels of 1,25-dihydroxyvitamin D, which is the active form of vitamin D, were linked to prolonged mechanical ventilation among COVID-19 patients.
In November 2022, a study published in the Nature Journal found that providing Vitamin D supplementation to U.S. veterans was associated with a reduced risk of COVID-19 infection.
The study also found that veterans receiving higher doses of Vitamin D had greater benefits from supplementation compared to those receiving lower doses, after controlling for vitamin D blood levels.
